Use of Digital Droplet PCR for Detecting EGFR T790M Resistance Mutation in Plasma at Progression on TKI Therapy

被引：0
|
作者：
Jonsson, M. [1 ]
Planck, M. [2 ]
Reutersward, C. [1 ]
Nilsson, I. [2 ]
Carlsson, M. [2 ]
George, A. [1 ]
Saal, L. [1 ]
Staaf, J. [1 ]
Isaksson, S. [1 ]
机构：
[1] Div Oncol & Pathol, Dept Clin Sci Lund, Lund, Sweden
[2] Skane Univ Hosp, Dept Resp Med & Allergol, Lund, Sweden
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
plasma; EGFR; ddPCR;
D O I：
10.1016/j.jtho.2019.08.2301
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.14-16
引用
收藏
页码：S1037 / S1038
页数：2
相关论文
共 50 条
  • [41] Quantification of T790M mutation in EGFR-mutant lung adenocarcinoma with nanofluidic digital PCR arrays.
    Isobe, Kazutoshi
    Hata, Yoshinobu
    Tochigi, Naobumi
    Kaburaki, Kyohei
    Makino, Takashi
    Otsuka, Hahjime
    Sato, Keita
    Sano, Go
    Sugino, Keishi
    Sakamoto, Susumu
    Takai, Yujiro
    Iyoda, Akira
    Homma, Sakae
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Detection of T790M gefitinib resistance mutation in EGFR using the BEAMing method
    Taniguchi, Kazuya
    Nishitani, Kimiyoshi
    Okami, Jiro
    Kodama, Ken
    Higashiyama, Masahiko
    Kato, Kikuya
    CANCER RESEARCH, 2010, 70
  • [43] Clinical Utility of Liquid Biopsy for Detecting EGFR T790M Mutation Is Very Limited
    Sakamoto, T.
    Yamane, K.
    Tanaka, N.
    Yanai, M.
    Izumi, H.
    Yamaguchi, K.
    Takeda, K.
    Makino, H.
    Igishi, T.
    Yamasaki, A.
    Simizu, E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2132 - S2132
  • [44] The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M
    Tseng, Jeng-Sen
    Su, Kang-Yi
    Yang, Tsung-Ying
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Chen, Hsuan-Yu
    Tsai, Chi-Ren
    Yu, Sung-Liang
    Chang, Gee-Chen
    ONCOTARGET, 2016, 7 (30) : 48059 - 48069
  • [45] A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance
    Wang, Wenxian
    Song, Zhengbo
    Zhang, Yiping
    CANCER MEDICINE, 2017, 6 (01): : 154 - 162
  • [46] The T790M "gatekeeper" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor
    Godin-Heymann, Nadia
    LlIkus, Lindsey
    Brannigan, Brian W.
    McDermott, Ultan
    Lamb, Jennifer
    Maheswaran, Shyamala
    Settleman, Jeffrey
    Haber, Daniel A.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (04) : 874 - 879
  • [47] Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance
    D. Zheng
    X. Ye
    M. Z. Zhang
    Y. Sun
    J. Y. Wang
    J. Ni
    H. P. Zhang
    L. Zhang
    J. Luo
    J. Zhang
    L. Tang
    B. Su
    G. Chen
    G. Zhu
    Y. Gu
    J. F. Xu
    Scientific Reports, 6
  • [48] Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance
    Zheng, D.
    Ye, X.
    Zhang, M. Z.
    Sun, Y.
    Wang, J. Y.
    Ni, J.
    Zhang, H. P.
    Zhang, L.
    Luo, J.
    Zhang, J.
    Tang, L.
    Su, B.
    Chen, G.
    Zhu, G.
    Gu, Y.
    Xu, J. F.
    SCIENTIFIC REPORTS, 2016, 6
  • [49] The EGFR T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor
    Kim, Youngwook
    Ko, Jeonghun
    Cui, ZhengYun
    Abolhoda, Amir
    Ahn, Jin Seok
    Ou, Sai-Hong
    Ahn, Myung-Ju
    Park, Keunchil
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) : 784 - 791
  • [50] The EGFR T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor
    Kim, Youngwook
    Ko, Jeonghun
    Cui, Zhengyun
    Abolhoda, Amir
    Lee, Jeeyun
    Ahn, Jinseok
    Ou, Sai-Hong
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S421 - S421
12345